Role of p53 in hematopoietic recovery after cytotoxic treatment.

Wlodarski, P; Wasik, M; Ratajczak, M Z; Sevignani, C; Hoser, G; Kawiak, J; Gewirtz, A M; Calabretta, B; Skorski, T

Wlodarski, P; Wasik, M; Ratajczak, M Z; Sevignani, C; Hoser, G; Kawiak, J; Gewirtz, A M; Calabretta, B; Skorski, T.

Affiliation

Wlodarski P; Department of Microbiology and Immunology, Kimmel Cancer Institute, Thomas Jefferson University, Philadelphia, PA, USA.

Blood ; 91(8): 2998-3006, 1998 Apr 15.

Article in En | MEDLINE | ID: mdl-9531612

Subject(s)

Antimetabolites/toxicity; Apoptosis/genetics; Fluorouracil/toxicity; Hematopoiesis/genetics; Tumor Suppressor Protein p53/genetics; Animals; Apoptosis/drug effects; Gene Expression Regulation/drug effects; Genes, Tumor Suppressor/genetics; Hematopoiesis/drug effects; Mice; Mice, Knockout

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tumor Suppressor Protein p53 / Apoptosis / Fluorouracil / Hematopoiesis / Antimetabolites Type of study: Prognostic_studies Limits: Animals Language: En Journal: Blood Year: 1998 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links